We are live on ! Find out more
MLL

Moody Lynn & Lieberson Portfolio holdings

AUM $1.9B
1-Year Est. Return 27.82%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$937M
AUM Growth
+$115M
Cap. Flow
-$2.54M
Cap. Flow %
-0.27%
Top 10 Hldgs %
29.62%
Holding
230
New
21
Increased
73
Reduced
77
Closed
23

Top Buys

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$13.7M
2
BIIB icon
Biogen
BIIB
+$11.6M
3
ITW icon
Illinois Tool Works
ITW
+$10.4M
4
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$9.01M
5
C icon
Citigroup
C
+$7.24M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$16.6M
2
FRC
First Republic Bank
FRC
+$11.7M
3
BCR
CR Bard Inc.
BCR
+$6.76M
4
GD icon
General Dynamics
GD
+$5.71M
5
GLD icon
SPDR Gold Trust
GLD
+$5.55M

Sector Composition

Rank Sector Weight
1 Financials 20.83%
2 Industrials 15.41%
3 Healthcare 11.28%
4 Technology 10.72%
5 Communication Services 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIDU icon
176
Baidu
BIDU
$37.7B
$381K 0.04%
+1,560
New +$381K
DVY icon
177
iShares Select Dividend ETF
DVY
$23.5B
$368K 0.04%
3,660
– –
SLB icon
178
SLB Ltd
SLB
$73.6B
$355K 0.04%
4,760
-66
-1% -$4.28K
FIS icon
179
Fidelity National Information Services
FIS
$23.1B
$353K 0.04%
3,440
– –
KMI icon
180
Kinder Morgan
KMI
$71.7B
$338K 0.04%
18,529
– –
TDG icon
181
TransDigm Group
TDG
$70.2B
$330K 0.04%
1,040
– –
ABBV icon
182
AbbVie
ABBV
$443B
$324K 0.03%
2,797
+200
+8% +$18.8K
EEM icon
183
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$292K 0.03%
5,770
-69
-1% -$3.19K
WAT icon
184
Waters Corp
WAT
$37B
$289K 0.03%
1,345
– –
ORCL icon
185
Oracle
ORCL
$374B
$284K 0.03%
5,575
– –
BF.B icon
186
Brown-Forman Class B
BF.B
$13.2B
$281K 0.03%
6,397
– –
RDS.A
187
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$281K 0.03%
4,010
– –
YUMC icon
188
Yum China
YUMC
$16.5B
$280K 0.03%
5,990
– –
WEC icon
189
WEC Energy
WEC
$35.7B
$262K 0.03%
4,130
-75
-2% -$5.03K
UN
190
DELISTED
Unilever NV New York Registry Shares
UN
$259K 0.03%
4,510
+71
+2% +$4.09K
GPC icon
191
Genuine Parts
GPC
$17.1B
$253K 0.03%
2,407
-26
-1% -$2.38K
PM icon
192
Philip Morris
PM
$297B
$235K 0.03%
2,176
-3,827
-64% -$408K
CHKP icon
193
Check Point Software Technologies
CHKP
$13B
$221K 0.02%
2,112
-190
-8% -$20.6K
ACWX icon
194
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$211K 0.02%
+4,000
New +$197K
HBAN icon
195
Huntington Bancshares
HBAN
$34.4B
$161K 0.02%
10,000
– –
MVF
196
DELISTED
BlackRock MuniVest Fund
MVF
$112K 0.01%
12,000
– –
AMGN icon
197
Amgen
AMGN
$208B
– –
-12,620
Closed -$2.35M
BAX icon
198
Baxter International
BAX
$13.5B
– –
-9,525
Closed -$598K
BSX icon
199
Boston Scientific
BSX
$69.5B
– –
-75,340
Closed -$2.2M
BTT icon
200
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
– –
-32,855
Closed -$745K
5 6 7
8
9

Similar funds

EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
OPCM
Osborne Partners Capital Management San Francisco, California $1.89B AUM 16.21% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM

Moody Lynn & Lieberson's Q4 2017 Portfolio in Review

As of Q4 2017, Moody Lynn & Lieberson held 230 positions worth $937M, up 14% from $822M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Moody Lynn & Lieberson's Q4 2017 filing shows 21 new, 73 increased, 77 reduced and 23 closed positions. Its largest new stake was Biogen: 36,202 shares worth $12.8M. The largest sale was Celgene Corp, an estimated $16.6M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Moody Lynn & Lieberson's largest Q4 2017 buy was Biogen: 36,202 shares worth $12.8M.
  • Moody Lynn & Lieberson added most to Vanguard FTSE Emerging Markets ETF in Q4 2017, an estimated $13.7M increase.
  • Moody Lynn & Lieberson's biggest Q4 2017 reduction was SPDR Gold Trust, cutting an estimated $5.55M.
  • Moody Lynn & Lieberson fully exited Celgene Corp in Q4 2017, selling an estimated $16.6M.
  • Moody Lynn & Lieberson's ten largest holdings make up 30% of its $937M portfolio in Q4 2017.
  • Moody Lynn & Lieberson opened 21 new positions and closed 23 in Q4 2017.
  • Moody Lynn & Lieberson's portfolio value rose 14% quarter-over-quarter to $937M.

Based on Moody Lynn & Lieberson's 13F filing for Q4 2017, filed 2 Feb 2018.